Additionally, genetic silencing or KO of ORC6 impeded the in vitro migration and invasion of P1 glioma cells, as assessed through the “Transwell” (Fig. 4G) and “Matrigel Transwell” (Fig. 4H) assays, respectively. This evidence concerns the gene ORC6 and central nervous system cancer.